Clinical Trial

Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 24, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Evaluation of the effects of body composition, psychosocial factors, and drug-related problems on clinical progression (such as toxicity, treatment response, and quality of life) in cancer patients treated with immune checkpoint inhibitors
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-18.
Trial Details
NCT Number NCT07130981
Lead Sponsor Hacettepe University
Conditions Cancer, Psychosocial Functioning, Treatment Side Effects, Cachexia
Enrollment 200 participants
Start Date 2025-09-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-24